HYBRIDOME CELL LINE, SECRETTING MONOCLONAL ANTIBODY AGAINST ANTIGENE DETERMINANTE NOC- 1 OF MALIGNANT MELANOM IN HUMAN

摘要

The hybridoma cell line applies to oncology. It has a high productivity in vitro, and the use of its secreted monoclonal antibody increases the degree of detection of the antigen determinant NOC-1. The line is created by fusion of splenocytes from immunized melanoma cells from mice, line BALB/c - with mouse myelin cells of the line P3x63 Ag 8.653 and is registered in NBPMKK under 216 1682.